Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
for Leukemia
53 locations incl. Goodyear
Sponsor: Daiichi Sankyo
Sex: All·Age: 18 - 70
Code: NCT06578247·Phase 3·Recruiting
District of Columbia has 904 paid clinical trials enrolling now across cities including Washington D.C., Georgetown and Multiple Locations. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .